Spironolactone has been used for many years to treat hair loss. In our experience it is most effective for patients with acne and/or hair loss due to hormonal imbalances.
This meta analysis demonstrates that there is no increased risk of cancer when using it. As with all medications spironolactone can have side effects and it is important to review potential side effects before using it.
https://jamanetwork.com/journals/jamadermatology/article-abstract/2788624
You Might Also Enjoy...
These are the first two CME articles on hair transplantation to ever be published in the leading peer reviewed journal in our field. I am proud to be one of its authors.
During the American Academy of Dermatology (AAD) virtual meeting experience, I was happy to participate in this very informative session on innovative therapeutic tools to slow hair loss and increase hair growth.
More promising news in the treatment of alopecia areata. More clinical trials are needed to ensure safety and efficacy but very promising.
For some highly motivated patients, a combination of two therapies can be effective in helping hair loss.
The New England Journal of Medicine published an interesting article on vaccine effectiveness and the need for boosters.
The attached article from the FDA outlines the medical risks associated with JAK(Janus kinase) inhibitors for the treatment of alopecia totalis and universalis.
